The American College of Endocrinology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation

The American College of Endocrinology designates this enduring activity for a maximum of 5.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Maintenance of Certification

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 5.75 MOC Medical Knowledge point(s) in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC point(s) equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

Lectures Included

• Disease State Network Year-in-Review: Nutrition and Obesity - Monica Agarwal, MD, MEHP, FACE; Reshmi Srinath, MD
• Precision Nutrition: Are We There Yet? - Zhaoping Li, MD, PhD
• Diabetes Diets: A Roundtable Discussion
• One Size Doesn’t Fit All: Pharmacotherapy, Endoscopic Devices and Metabolic Surgery for the Management of Obesity
• A Blind Spot: Weight Bias and Health Disparities in Obesity Care - Scott Kahan, MD, MPH, FTOS

Learning Objectives

Upon completion of the activity, participants should be able to:

• Assess recent research and clinical trials of dietary patterns, lifestyle interventions, bariatric/metabolic surgery and weight management medications
• Develop an integrative individualized approach to help our patients with metabolic disease
• Summarize the safety and efficacy of intermittent fasting diets, including time-restricted feeding, in the management of T2DM
• Identify the magnitude and importance of weight bias in healthcare settings and several strategies for mitigating weight bias in clinical practice.
• Review the impact of endoscopic manipulation of the gastrointestinal tract on appetite and estimate expected weight loss outcomes of currently available drugs and those on the horizon

This educational initiative is intended for Endocrinologists.

Disclosure Policy

In accordance with the ACCME Standards for Commercial Support, The American Association of Clinical Endocrinology (AACE) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. AACE resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all their educational programs. Furthermore, AACE seeks to verify that all scientific research referred to, reported, or used in a CME/CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. AACE is committed to providing learners with high-quality CME.

Activity Staff Disclosures

The planners, reviewers, editors, staff, CME committee, and other members at the American Association of Clinical Endocrinology who control content have no relevant financial relationships to disclose.

Faculty Disclosures

• Scott Kahan, MD, MPH, FTOS - MALE NCWW/JHU: Nothing to disclose. 
• Martin M Grajower, MD, FACP, FACE - Clinical Professor of Medicine Albert Einstein College of Medicine: Abbott/AbbVie (Self: 1 financial relationship declared - Honorarium) Bayer (Self: 1 financial relationship declared - Honorarium) echosense (Self: 1 financial relationship declared - Honorarium) Novo Nordisk (Self: 1 financial relationship declared - Honorarium)
  
• Amy Fischl, MS RDN LDN BC-ADM CDCES - University of Chicago: Abbott Diabetes Care (Self: 1 financial relationship declared - Honorarium)    
  Xeris Pharmaceuticals (Self: 1 financial relationship declared - Honorarium) 
• Monica Agarwal, MD, MEHP, FACE - Associate Professor University of Alabama at Birmingham: Nothing to disclose.
  
• Reshmi Srinath, MD - Assistant Professor/Director Weight and Metabolism Management Program Icahn School of Medicine at Mount Sinai: Nothing to disclose. 
  
• Barham Abu Dayyeh, MD, MPH - Director of Advanced Endoscopy and Vice Chair of Innovation Mayo Clinic, Rochester, MN: Apollo Endo-surgery (Self: 1 financial relationship declared - Grant/Research Support) Boston Scientific (Self: 1 financial relationship declared - Grant/Research Support) 
  Endogenex (Self: 1 financial relationship declared - Ownership Interest includes stock, stock options, patent or other intellectual property)    
  Spatz Medical (Self: 1 financial relationship declared - Grant/Research Support) USGI Medical (Self: 1 financial relationship declared - Grant/Research Support) 
  
• Taraneh Solymani, MD - Associate Professor Penn State College of Medicine: Nothing to disclose.
  
• Teresa LaMasters, MD - Medical Director Bariatric Surgery UnityPoint Clinic Weight Loss Specialists: ASMBS (Self: 1 financial relationship declared - Reimbursement for travel and registration as a speaker and board member) Ethicon (Self: 2 financial relationships declared - Honorarium, Consulting Fees (e.g., advisory boards)) INTUITIVE SURGICAL (Self: 2 financial relationships declared - Honorarium, Consulting Fees (e.g., advisory boards)) WL Gore (Self: 2 financial relationships declared - Honorarium, Consulting Fees (e.g., advisory boards))
  
• Holly F Lofton, MD, DiplABOM - Clinical Associate Professor of Surgery and Medicine NYU Grossman School of Medicine: Eli Lilly (Self: 1 financial relationship declared - Research Grant includes principal investigator, collaborator or consultant and pending grants as well as grants already received) Novo Nordisk (Self: 3 financial relationships declared - Honorarium, Consulting Fees (e.g., advisory boards), Research Grant includes principal investigator, collaborator or consultant and pending grants as well as grants already received)
  
• Zhaoping Li, MD, PhD - UCLA: Nothing to disclose

Disclosure of Unlabeled Use

• Monica Agarwal, MD, MEHP, FACE
• Reshmi Srinath, MD
• Scott Kahan, MD, MPH, FTOS
• Martin M Grajower, MD, FACP, FACE
• Amy Fischl, MS RDN LDN BC-ADM CDCES
• Barham Abu Dayyeh, MD, MPH
• Taraneh Solymani, MD
• Teresa LaMasters, MD
• Holly F Lofton, MD, DiplABOM
• Zhaoping Li, MD, PhD